Thermo Fisher Scientific Inc. (TMO)

NYSE: TMO · IEX Real-Time Price · USD

533.93

-7.79 (-1.44%)

At close: Jul 2, 2024, 4:00 PM

534.00

+0.07 (0.01%)

After-hours: Jul 2, 2024, 7:55 PM EDT

Thermo Fisher Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	5,995	6,950	7,725	6,375	3,696	Upgrade
Depreciation & Amortization	3,406	3,381	2,592	2,325	2,277	Upgrade
Share-Based Compensation	278	307	230	196	181	Upgrade
Other Operating Activities	-1,273	-1,484	-1,235	-607	-1,181	Upgrade
Operating Cash Flow	8,406	9,154	9,312	8,289	4,973	Upgrade
Operating Cash Flow Growth	-8.17%	-1.70%	12.34%	66.68%	9.47%	Upgrade
Capital Expenditures	-1,392	-2,219	-2,503	-1,466	-890	Upgrade
Acquisitions	-3,660	-39	-19,395	-38	-715	Upgrade
Other Investing Activities	-90	99	-34	-6	118	Upgrade
Investing Cash Flow	-5,142	-2,159	-21,932	-1,510	-1,487	Upgrade
Dividends Paid	-523	-455	-395	-337	-297	Upgrade
Share Issuance / Repurchase	-3,000	-3,000	-2,000	-1,500	-1,347	Upgrade
Debt Issued / Paid	-155	654	8,911	2,750	-1,400	Upgrade
Other Financing Activities	56	-9	65	46	-74	Upgrade
Financing Cash Flow	-3,622	-2,810	6,581	959	-3,118	Upgrade
Exchange Rate Effect	-82	-139	194	176	-63	Upgrade
Net Cash Flow	-440	4,046	-5,845	7,914	305	Upgrade
Free Cash Flow	7,014	6,935	6,809	6,823	4,083	Upgrade
Free Cash Flow Growth	1.14%	1.85%	-0.21%	67.11%	6.47%	Upgrade
Free Cash Flow Margin	16.37%	15.44%	17.37%	21.18%	15.99%	Upgrade
Free Cash Flow Per Share	18.17	17.69	17.28	17.23	10.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).